Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans

Roongpetch Keowkase, Marwa Aboukhatwa, Bao Ling Adam, J. Warren Beach, Alvin V Terry, Jerry J. Buccafussco, Yuan Luo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Our previous work indicated that novel analogs of choline have cytoprotective effects in vitro that might be useful in neurodegenerative conditions such as Alzheimer's disease (AD). Furthermore, two lead compounds (JWB1-84-1 and JAY2-22-33) from a library of more than 50 improved cognitive performances in a transgenic mouse model of AD. The purpose of these experiments was to more specifically investigate the neuroprotective capabilities of these lead compounds both in vitro and in vivo. Results. We used N2a cells which express a Swedish mutation in the amyloid precursor protein and presenilin 1 genes to investigate the effect of JWB1-84-1 and JAY2-22-33 on -amyloid (A) levels and found that both compounds significantly reduced A levels. JWB1-84-1 and JAY2-22-33 also protected rat primary cortical neurons from A toxicity. Subsequently, we utilized the nematode Caenorhabditis elegans (C. elegans) as an in vivo model organism to identify potential molecular targets of these compounds. In the C. elegans model of A toxicity, human A is expressed intracellularly in the body wall muscle. The expression and subsequent aggregation of A in the muscle leads to progressive paralysis. Conclusion. We found that JAY2-22-33 (but not JWB1-84-1) significantly reduced A toxicity by delaying paralysis and this protective effect required both the insulin signaling pathway and nicotinic acetylcholine receptors (nAChRs).

Original languageEnglish (US)
Article number59
JournalMolecular Neurodegeneration
Volume5
Issue number1
DOIs
StatePublished - Dec 20 2010

Fingerprint

Caenorhabditis elegans
Neuroprotective Agents
Choline
Paralysis
Alzheimer Disease
Presenilin-1
Muscles
Amyloid beta-Protein Precursor
Nicotinic Receptors
Amyloid
Transgenic Mice
Libraries
Insulin
Neurons
Mutation
JWB-1-84-1
Genes
In Vitro Techniques

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans. / Keowkase, Roongpetch; Aboukhatwa, Marwa; Adam, Bao Ling; Beach, J. Warren; Terry, Alvin V; Buccafussco, Jerry J.; Luo, Yuan.

In: Molecular Neurodegeneration, Vol. 5, No. 1, 59, 20.12.2010.

Research output: Contribution to journalArticle

Keowkase, Roongpetch ; Aboukhatwa, Marwa ; Adam, Bao Ling ; Beach, J. Warren ; Terry, Alvin V ; Buccafussco, Jerry J. ; Luo, Yuan. / Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans. In: Molecular Neurodegeneration. 2010 ; Vol. 5, No. 1.
@article{46460172b57c4e73bfcbd2d7edf2cab0,
title = "Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans",
abstract = "Background: Our previous work indicated that novel analogs of choline have cytoprotective effects in vitro that might be useful in neurodegenerative conditions such as Alzheimer's disease (AD). Furthermore, two lead compounds (JWB1-84-1 and JAY2-22-33) from a library of more than 50 improved cognitive performances in a transgenic mouse model of AD. The purpose of these experiments was to more specifically investigate the neuroprotective capabilities of these lead compounds both in vitro and in vivo. Results. We used N2a cells which express a Swedish mutation in the amyloid precursor protein and presenilin 1 genes to investigate the effect of JWB1-84-1 and JAY2-22-33 on -amyloid (A) levels and found that both compounds significantly reduced A levels. JWB1-84-1 and JAY2-22-33 also protected rat primary cortical neurons from A toxicity. Subsequently, we utilized the nematode Caenorhabditis elegans (C. elegans) as an in vivo model organism to identify potential molecular targets of these compounds. In the C. elegans model of A toxicity, human A is expressed intracellularly in the body wall muscle. The expression and subsequent aggregation of A in the muscle leads to progressive paralysis. Conclusion. We found that JAY2-22-33 (but not JWB1-84-1) significantly reduced A toxicity by delaying paralysis and this protective effect required both the insulin signaling pathway and nicotinic acetylcholine receptors (nAChRs).",
author = "Roongpetch Keowkase and Marwa Aboukhatwa and Adam, {Bao Ling} and Beach, {J. Warren} and Terry, {Alvin V} and Buccafussco, {Jerry J.} and Yuan Luo",
year = "2010",
month = "12",
day = "20",
doi = "10.1186/1750-1326-5-59",
language = "English (US)",
volume = "5",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans

AU - Keowkase, Roongpetch

AU - Aboukhatwa, Marwa

AU - Adam, Bao Ling

AU - Beach, J. Warren

AU - Terry, Alvin V

AU - Buccafussco, Jerry J.

AU - Luo, Yuan

PY - 2010/12/20

Y1 - 2010/12/20

N2 - Background: Our previous work indicated that novel analogs of choline have cytoprotective effects in vitro that might be useful in neurodegenerative conditions such as Alzheimer's disease (AD). Furthermore, two lead compounds (JWB1-84-1 and JAY2-22-33) from a library of more than 50 improved cognitive performances in a transgenic mouse model of AD. The purpose of these experiments was to more specifically investigate the neuroprotective capabilities of these lead compounds both in vitro and in vivo. Results. We used N2a cells which express a Swedish mutation in the amyloid precursor protein and presenilin 1 genes to investigate the effect of JWB1-84-1 and JAY2-22-33 on -amyloid (A) levels and found that both compounds significantly reduced A levels. JWB1-84-1 and JAY2-22-33 also protected rat primary cortical neurons from A toxicity. Subsequently, we utilized the nematode Caenorhabditis elegans (C. elegans) as an in vivo model organism to identify potential molecular targets of these compounds. In the C. elegans model of A toxicity, human A is expressed intracellularly in the body wall muscle. The expression and subsequent aggregation of A in the muscle leads to progressive paralysis. Conclusion. We found that JAY2-22-33 (but not JWB1-84-1) significantly reduced A toxicity by delaying paralysis and this protective effect required both the insulin signaling pathway and nicotinic acetylcholine receptors (nAChRs).

AB - Background: Our previous work indicated that novel analogs of choline have cytoprotective effects in vitro that might be useful in neurodegenerative conditions such as Alzheimer's disease (AD). Furthermore, two lead compounds (JWB1-84-1 and JAY2-22-33) from a library of more than 50 improved cognitive performances in a transgenic mouse model of AD. The purpose of these experiments was to more specifically investigate the neuroprotective capabilities of these lead compounds both in vitro and in vivo. Results. We used N2a cells which express a Swedish mutation in the amyloid precursor protein and presenilin 1 genes to investigate the effect of JWB1-84-1 and JAY2-22-33 on -amyloid (A) levels and found that both compounds significantly reduced A levels. JWB1-84-1 and JAY2-22-33 also protected rat primary cortical neurons from A toxicity. Subsequently, we utilized the nematode Caenorhabditis elegans (C. elegans) as an in vivo model organism to identify potential molecular targets of these compounds. In the C. elegans model of A toxicity, human A is expressed intracellularly in the body wall muscle. The expression and subsequent aggregation of A in the muscle leads to progressive paralysis. Conclusion. We found that JAY2-22-33 (but not JWB1-84-1) significantly reduced A toxicity by delaying paralysis and this protective effect required both the insulin signaling pathway and nicotinic acetylcholine receptors (nAChRs).

UR - http://www.scopus.com/inward/record.url?scp=78650102379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650102379&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-5-59

DO - 10.1186/1750-1326-5-59

M3 - Article

VL - 5

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 59

ER -